Biomaterials Journal https://biomatj.com/ojs/index.php/main <p><em><strong>Biomaterials Journal (Biomat.J.)</strong></em> is an international, open access, peer-reviewed journal that provides monthly publication of articles, published by Biomaterials Department <strong> <a href="https://portal.issn.org/resource/ISSN/2812-5045" target="_blank" rel="noopener"> (Online ISSN:2812-5045)</a></strong> and publishes papers on the theory, design, engineering, fabrication, and implementation of materials or devices with valuable applications in biological systems. The journal welcomes studies from the full range of materials and technologies employed <em>in vitro</em> and <em>in vivo</em>, as well as clinical studies.</p> <p>As well as original research,<em> <strong>Biomaterials Journal</strong></em> also publishes case study, survey study, mini-reviews, and reviews articles that examine the state of the art, identify emerging trends, and suggest future directions for developing fields.</p> <p>The article processing charge (APC) is <strong>only 150$ USD</strong> upon manuscript acceptance to cover the range of publishing services we provide. This includes the provision of online tools for editors and authors, article production and hosting, indexing services, and customer services.</p> <p><strong>Call For Paper Volume 4 Issue No. 2 (February 2025)</strong></p> <p>The call for new manuscript submissions is <strong>open now</strong>. We offer waivers and discounts for article processing charges (APCs) for articles <span style="font-size: 0.875rem;">to be only 130$ (instead of 150$) for a limited time upon acceptance.</span></p> <p><strong>Deadline time:</strong> 20 February 2025</p> <p><strong>Decision:</strong> 3-10 days</p> <p><strong>Publication date:</strong> 25 February 2025</p> en-US <p><em>Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under <strong> <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank" rel="noopener"> a Commons Attribution 4.0 International License</a></strong> that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal</em></p> admin@biomaj.com (Editor-in-chief) biomatj.com @ gmail.com (Technical Support) Sun, 26 Jan 2025 19:51:31 +0000 OJS 3.3.0.8 http://blogs.law.harvard.edu/tech/rss 60 Bioactive Materials for the Future of Dentistry https://biomatj.com/ojs/index.php/main/article/view/140 <p>The term bioactivity is becoming more common in the fields of medicine and dentistry. Its positive implications often lead to its use in marketing dental restorative materials. However, there is some confusion surrounding the definition of the term, and concerns about its potential overuse have been raised. In response, FDI has decided to publish a Policy Statement regarding the bioactivity of dental restorative materials to clarify the term and outline some precautions for its use in advertising. The background information for this Policy Statement was gathered from current literature, primarily from the PubMed database and various online sources. Bioactive restorative materials should provide beneficial effects that are local, intended, and non-toxic, without interfering with the primary function of the material, which is to replace dental tissue. Three mechanisms of bioactivity for these materials have been identified: purely biological, a combination of biological and chemical, or strictly chemical. When the term bioactivity appears in advertisements or descriptions of dental restorative materials, it is essential to provide scientific evidence—whether from in vitro or in situ studies, and ideally from clinical trials—that outlines the mechanism of action, the duration of the effect (particularly for materials that release antibacterial agents), and the absence of significant adverse biological side effects, such as the development and spread of antimicrobial resistance. Also, it must be proven that the main goal—like fixing the shape and function of damaged or missing teeth—is not harmed. This should be backed up by data from lab tests and studies on patients.</p> Tamer Hamdy Copyright (c) 2025 Tamer Hamdy https://creativecommons.org/licenses/by/4.0 https://biomatj.com/ojs/index.php/main/article/view/140 Sun, 26 Jan 2025 00:00:00 +0000 Coatings for Dental Materials: How They Affect Clinical Performance https://biomatj.com/ojs/index.php/main/article/view/142 <p>Contemporary dentistry embraces digital procedures and advanced biomaterials to improve patients' quality of life. As practitioners, we are encouraged to adapt in every aspect of our work, from diagnosis to the creation of prosthetics. The latest biomaterials need to be more damage-tolerant and capable of ensuring longer-lasting results. Consequently, biomimetic replacements, tissue engineering scaffolds, and even cloned teeth could represent the best options for future treatments.</p> Rasha Abdelraouf Copyright (c) 2025 Rasha Abdelraouf https://creativecommons.org/licenses/by/4.0 https://biomatj.com/ojs/index.php/main/article/view/142 Sun, 26 Jan 2025 00:00:00 +0000 Preparation, characterization, and functional properties of ternary composite nanoparticles for enhanced bioaccessibility and antitumor activity of cannabidiol https://biomatj.com/ojs/index.php/main/article/view/125 <p>Cannabidiol (CBD) faces challenges in food and pharmaceutical use due to poor solubility and stability. A novel CBD delivery system using stearic acid-modified Bletilla striata polysaccharides (SA-BSPs) was developed, improving encapsulation and release. Optimal encapsulation efficiency (92.07%) and loading capacity (8.94%) were achieved with a 3:10 CBD to SA-BSPs ratio. The system showed sustained release over a week and strong binding affinity to CB1 receptors. CBD-SA-BSPs copolymer micelles effectively suppressed the proliferation and reduced the viability of MHCC-97H and HCCLM3 cells, particularly the CBD-SA-BSPs (3:10) at a concentration of 20 µg/mL. Compared with the model group, the levels of IL-2, IL-6, and TNF-α in the serum of mice in the drug-administered groups were significantly reduced, suggesting that the drug may exert its anti-hepatocarcinoma effect by regulating the levels of these cytokines. In vivo study results showed that the tumor inhibition rate of 10mg/kg CBD-SA-BSPs (3:10) group was as high as 72.83%, revealing polymer micelles have potential for future therapeutic applications.</p> zhoushan wu Copyright (c) 2025 zhoushan wu https://creativecommons.org/licenses/by/4.0 https://biomatj.com/ojs/index.php/main/article/view/125 Sun, 26 Jan 2025 00:00:00 +0000 Assessment of knowledge, awareness and practices toward the use of 3D technology in planning and performing oral surgeries among dentists: A cross-sectional study https://biomatj.com/ojs/index.php/main/article/view/143 <p><strong>Background:</strong> The three-dimensional (3D) imaging technology is a contemporary technique that allows for the creation of very clear and detailed 3D pictures of teeth, jaw, and surrounding structure. In oral surgery, it leads to the enhancement of the diagnosis, planning, and implementation of oral surgical procedures. <strong>Objectives:</strong> Assessment of the knowledge, awareness and practices toward the use of 3D imaging technology in planning and performing oral surgeries among dentists in Libya.<strong> Materials and Methods:</strong> through January 2025, a cross-sectional questionnaire-based study was employed among dentists with different academic degree (BDS, Master and PhD holder) in Libya, to evaluate the awareness and use of 3D technology among oral surgeons and general dental practitioners (GDPs) utilizing Google Forms and incorporating qualitative questions.<strong> Results: </strong>Based on the questionnaire responses, it can be concluded that the feedback regarding the use of 3D technology in oral surgeries among oral surgeons and GDPs is favorable. <strong>Conclusion: </strong>Dentists have a reasonable level of awareness regarding 3D technology in the planning and execution of oral surgeries, which will improve their surgical performance. </p> <p>&nbsp;</p> Ghada Salem Awad Ali, Gada Abdul Hafiz Ahmed Ali Copyright (c) 2025 Ghada Salem Awad Ali, Gada Abdul Hafiz Ahmed Ali https://creativecommons.org/licenses/by/4.0 https://biomatj.com/ojs/index.php/main/article/view/143 Sun, 26 Jan 2025 00:00:00 +0000